ADAM17 and Insulin resistance: In the milieu of T2DM, elevated chronic plasma levels of TNF-α, a consequence of ADAM17's shedding activity, promote insulin resistance [116, 117], thereby decreasing the activation of the PI3K/AKT pathway [20].